精密医療のグローバル市場2023~2027:腫瘍、中枢神経系疾患、呼吸器疾患、免疫疾患、その他

【英語タイトル】Global Precision Medicine Market 2023-2027

Technavioが出版した調査資料(IRTNTR75258-23)・商品コード:IRTNTR75258-23
・発行会社(調査会社):Technavio
・発行日:2023年5月4日
・ページ数:約120
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:北米、ヨーロッパ、アジア太平洋、アメリカ、ドイツ、中国、イギリス、日本、その他地域
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥380,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥608,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Technavio社の本市場調査レポートでは、世界の精密医療市場規模が2022年から2027年の間に540.7億ドルまで到達し、予測期間中に年平均11.32%成長すると見込まれます。本レポートでは精密医療の世界市場について多角的に調査・分析し、エグゼクティブサマリー、市場状況、市場規模予測、過去の市場規模、ファイブフォース分析、用途別(腫瘍、中枢神経系疾患、呼吸器疾患、免疫疾患、その他)分析、技術別(バイオインフォマティクス、遺伝子配列決定、創薬、精密分子診断、ビッグデータ分析)分析、地域別状況(北米、ヨーロッパ、アジア太平洋、アメリカ、ドイツ、中国、イギリス、日本、その他)分析、成長要因・課題・動向、企業状況、企業分析などの内容を掲載しています。なお、参入企業情報としてAbbVie Inc.、Amgen Inc.、AstraZeneca Plc、Biocrates Life Sciences AG、Bristol Myers Squibb Co.、Catalent Inc.、Eli Lilly and Co.、F. Hoffmann La Roche Ltd.、Gilead Sciences Inc.、IQVIA Holdings Inc.、Johnson and Johnson Services Inc.などが含まれています。
・市場状況
・市場規模予測
・過去の市場規模
・ファイブフォース分析
・世界の精密医療市場規模:用途別
- 腫瘍における市場規模
- 中枢神経系疾患における市場規模
- 呼吸器疾患における市場規模
- 免疫疾患における市場規模
- その他用途における市場規模
・世界の精密医療市場規模:技術別
- バイオインフォマティクス技術の市場規模
- 遺伝子配列決定バイオインフォマティクス技術の市場規模
- 創薬バイオインフォマティクス技術の市場規模
- 精密分子診断バイオインフォマティクス技術の市場規模
- ビッグデータ分析バイオインフォマティクス技術の市場規模
・地域別状況
- 北米の精密医療市場規模
- ヨーロッパの精密医療市場規模
- アジア太平洋の精密医療市場規模
- その他地域の精密医療市場規模
- アメリカの精密医療市場規模
- ドイツの精密医療市場規模
- 中国の精密医療市場規模
- イギリスの精密医療市場規模
- 日本の精密医療市場規模
・成長要因・課題・動向
・企業状況
・企業分析

Technavio社は、利益、価格、競争、プロモーションなどの主要な変数を分析することで、また、複数のソースからのデータを調査・統合・合計することにより、精密医療市場の詳細な全体像を提示します。主要産業のインフルエンサーを特定することで、さまざまな市場の側面を提示します。提示されたデータは包括的​​で信頼性が高く、一次および二次の広範な調査の結果です。Technavio社の市場調査レポートは、正確な精密医療市場の成長を予測するための定性的・定量的調査を用い、徹底的な競合状況と詳細に及ぶベンダー選定・分析を提供します。

精密医療の世界市場 2023-2027

精密医療市場は、2022年から2027年にかけて540.7億米ドルの成長が予測され、予測期間中のCAGRは11.32%で加速すると予測されています。当レポートでは、精密医療市場の全体的な分析、市場規模、予測、動向、成長促進要因、課題に加え、約25のベンダーを網羅したベンダー分析も提供しています。
当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、慢性疾患の有病率の増加、個別化医療に対する需要の高まり、ゲノミクスとプロテオミクスの進歩によって牽引されています。

Technavio社の精密医療市場は以下のように区分されます:

・用途別:
– 腫瘍学
– 中枢神経系
– 呼吸器
– 免疫学
– その他

・技術別:
– バイオインフォマティクス
– 遺伝子シーケンス
– 創薬
– 精密分子診断
– ビッグデータ分析

・地域別:
– 北米
– ヨーロッパ
– アジア
– その他の地域(ROW)

本調査では、人工知能(AI)と機械学習(ML)の利用が拡大していることを明らかにしました。および機械学習(ML) 本調査では、精密医療における人工知能(AI)および機械学習(ML)の利用の拡大が、今後数年間の精密医療市場の成長を促進する主な要因の1つであると指摘しています。また、ゲノミクスとデジタルヘルスの統合、精密医療における最近の開発の拡大は、市場の大きな需要につながるでしょう。

精密医療市場に関するレポートは以下の分野をカバーしています:
– 精密医療市場のサイジング
– 精密医療市場の予測
– 精密医療市場の産業分析

強固なベンダー分析は、クライアントが市場でのポジションを向上できるように設計されており、これに沿って本レポートには、AbbVie Inc., Amgen Inc., AstraZeneca Plc, Biocrates Life Sciences AG, Bristol Myers Squibb Co., Catalent Inc., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., IQVIA Holdings Inc., Johnson and Johnson Services Inc., Lonza Group Ltd., Merck and Co. Inc., Novartis AG, Parexel International Corp., Pfizer Inc., QIAGEN NV, Sanofi SA, Takeda Pharmaceutical Co. Ltd., and Thermo Fisher Scientific Incなどの企業情報が含まれています。また、精密医療市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を練り、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。当レポートでは、主要ベンダーの分析に加え、包括的な市場とベンダーの状況を掲載しています。

当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析を通じて、複数の情報源からのデータを調査、統合、総括することにより、市場の詳細な姿を提示しています。業界の主要な影響者を特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Technology
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ billion)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global precision medicine market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on global precision medicine market 2017 – 2021 ($ billion)
o 4.2 Application Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Application Segment 2017 – 2021 ($ billion)
o 4.3 Technology Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Technology Segment 2017 – 2021 ($ billion)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ billion)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Application
o 6.1 Market segments
o Exhibit 30: Chart on Application – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Application – Market share 2022-2027 (%)
o 6.2 Comparison by Application
o Exhibit 32: Chart on Comparison by Application
o Exhibit 33: Data Table on Comparison by Application
o 6.3 Oncology – Market size and forecast 2022-2027
o Exhibit 34: Chart on Oncology – Market size and forecast 2022-2027 ($ billion)
o Exhibit 35: Data Table on Oncology – Market size and forecast 2022-2027 ($ billion)
o Exhibit 36: Chart on Oncology – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Oncology – Year-over-year growth 2022-2027 (%)
o 6.4 CNS – Market size and forecast 2022-2027
o Exhibit 38: Chart on CNS – Market size and forecast 2022-2027 ($ billion)
o Exhibit 39: Data Table on CNS – Market size and forecast 2022-2027 ($ billion)
o Exhibit 40: Chart on CNS – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on CNS – Year-over-year growth 2022-2027 (%)
o 6.5 Respiratory – Market size and forecast 2022-2027
o Exhibit 42: Chart on Respiratory – Market size and forecast 2022-2027 ($ billion)
o Exhibit 43: Data Table on Respiratory – Market size and forecast 2022-2027 ($ billion)
o Exhibit 44: Chart on Respiratory – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Respiratory – Year-over-year growth 2022-2027 (%)
o 6.6 Immunology – Market size and forecast 2022-2027
o Exhibit 46: Chart on Immunology – Market size and forecast 2022-2027 ($ billion)
o Exhibit 47: Data Table on Immunology – Market size and forecast 2022-2027 ($ billion)
o Exhibit 48: Chart on Immunology – Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Immunology – Year-over-year growth 2022-2027 (%)
o 6.7 Others – Market size and forecast 2022-2027
o Exhibit 50: Chart on Others – Market size and forecast 2022-2027 ($ billion)
o Exhibit 51: Data Table on Others – Market size and forecast 2022-2027 ($ billion)
o Exhibit 52: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 53: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 6.8 Market opportunity by Application
o Exhibit 54: Market opportunity by Application ($ billion)
o Exhibit 55: Data Table on Market opportunity by Application ($ billion)
• 7 Market Segmentation by Technology
o 7.1 Market segments
o Exhibit 56: Chart on Technology – Market share 2022-2027 (%)
o Exhibit 57: Data Table on Technology – Market share 2022-2027 (%)
o 7.2 Comparison by Technology
o Exhibit 58: Chart on Comparison by Technology
o Exhibit 59: Data Table on Comparison by Technology
o 7.3 Bioinformatics – Market size and forecast 2022-2027
o Exhibit 60: Chart on Bioinformatics – Market size and forecast 2022-2027 ($ billion)
o Exhibit 61: Data Table on Bioinformatics – Market size and forecast 2022-2027 ($ billion)
o Exhibit 62: Chart on Bioinformatics – Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Bioinformatics – Year-over-year growth 2022-2027 (%)
o 7.4 Gene sequencing – Market size and forecast 2022-2027
o Exhibit 64: Chart on Gene sequencing – Market size and forecast 2022-2027 ($ billion)
o Exhibit 65: Data Table on Gene sequencing – Market size and forecast 2022-2027 ($ billion)
o Exhibit 66: Chart on Gene sequencing – Year-over-year growth 2022-2027 (%)
o Exhibit 67: Data Table on Gene sequencing – Year-over-year growth 2022-2027 (%)
o 7.5 Drug discovery – Market size and forecast 2022-2027
o Exhibit 68: Chart on Drug discovery – Market size and forecast 2022-2027 ($ billion)
o Exhibit 69: Data Table on Drug discovery – Market size and forecast 2022-2027 ($ billion)
o Exhibit 70: Chart on Drug discovery – Year-over-year growth 2022-2027 (%)
o Exhibit 71: Data Table on Drug discovery – Year-over-year growth 2022-2027 (%)
o 7.6 Precision molecular diagnostic – Market size and forecast 2022-2027
o Exhibit 72: Chart on Precision molecular diagnostic – Market size and forecast 2022-2027 ($ billion)
o Exhibit 73: Data Table on Precision molecular diagnostic – Market size and forecast 2022-2027 ($ billion)
o Exhibit 74: Chart on Precision molecular diagnostic – Year-over-year growth 2022-2027 (%)
o Exhibit 75: Data Table on Precision molecular diagnostic – Year-over-year growth 2022-2027 (%)
o 7.7 Big data analytics – Market size and forecast 2022-2027
o Exhibit 76: Chart on Big data analytics – Market size and forecast 2022-2027 ($ billion)
o Exhibit 77: Data Table on Big data analytics – Market size and forecast 2022-2027 ($ billion)
o Exhibit 78: Chart on Big data analytics – Year-over-year growth 2022-2027 (%)
o Exhibit 79: Data Table on Big data analytics – Year-over-year growth 2022-2027 (%)
o 7.8 Market opportunity by Technology
o Exhibit 80: Market opportunity by Technology ($ billion)
o Exhibit 81: Data Table on Market opportunity by Technology ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 82: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 83: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 84: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 85: Chart on Geographic comparison
o Exhibit 86: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 87: Chart on North America – Market size and forecast 2022-2027 ($ billion)
o Exhibit 88: Data Table on North America – Market size and forecast 2022-2027 ($ billion)
o Exhibit 89: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 91: Chart on Europe – Market size and forecast 2022-2027 ($ billion)
o Exhibit 92: Data Table on Europe – Market size and forecast 2022-2027 ($ billion)
o Exhibit 93: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 95: Chart on Asia – Market size and forecast 2022-2027 ($ billion)
o Exhibit 96: Data Table on Asia – Market size and forecast 2022-2027 ($ billion)
o Exhibit 97: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 99: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
o Exhibit 100: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
o Exhibit 101: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 103: Chart on US – Market size and forecast 2022-2027 ($ billion)
o Exhibit 104: Data Table on US – Market size and forecast 2022-2027 ($ billion)
o Exhibit 105: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Germany – Market size and forecast 2022-2027
o Exhibit 107: Chart on Germany – Market size and forecast 2022-2027 ($ billion)
o Exhibit 108: Data Table on Germany – Market size and forecast 2022-2027 ($ billion)
o Exhibit 109: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 110: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.9 China – Market size and forecast 2022-2027
o Exhibit 111: Chart on China – Market size and forecast 2022-2027 ($ billion)
o Exhibit 112: Data Table on China – Market size and forecast 2022-2027 ($ billion)
o Exhibit 113: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 114: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.10 UK – Market size and forecast 2022-2027
o Exhibit 115: Chart on UK – Market size and forecast 2022-2027 ($ billion)
o Exhibit 116: Data Table on UK – Market size and forecast 2022-2027 ($ billion)
o Exhibit 117: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 118: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.11 Japan – Market size and forecast 2022-2027
o Exhibit 119: Chart on Japan – Market size and forecast 2022-2027 ($ billion)
o Exhibit 120: Data Table on Japan – Market size and forecast 2022-2027 ($ billion)
o Exhibit 121: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 122: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 123: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 124: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 125: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 126: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 127: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 128: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 129: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 130: Matrix on vendor position and classification
o 12.3 Amgen Inc.
o Exhibit 131: Amgen Inc. – Overview
o Exhibit 132: Amgen Inc. – Product / Service
o Exhibit 133: Amgen Inc. – Key offerings
o 12.4 AstraZeneca Plc
o Exhibit 134: AstraZeneca Plc – Overview
o Exhibit 135: AstraZeneca Plc – Product / Service
o Exhibit 136: AstraZeneca Plc – Key news
o Exhibit 137: AstraZeneca Plc – Key offerings
o 12.5 Bristol Myers Squibb Co.
o Exhibit 138: Bristol Myers Squibb Co. – Overview
o Exhibit 139: Bristol Myers Squibb Co. – Product / Service
o Exhibit 140: Bristol Myers Squibb Co. – Key news
o Exhibit 141: Bristol Myers Squibb Co. – Key offerings
o 12.6 Catalent Inc.
o Exhibit 142: Catalent Inc. – Overview
o Exhibit 143: Catalent Inc. – Business segments
o Exhibit 144: Catalent Inc. – Key news
o Exhibit 145: Catalent Inc. – Key offerings
o Exhibit 146: Catalent Inc. – Segment focus
o 12.7 Eli Lilly and Co.
o Exhibit 147: Eli Lilly and Co. – Overview
o Exhibit 148: Eli Lilly and Co. – Product / Service
o Exhibit 149: Eli Lilly and Co. – Key offerings
o 12.8 F. Hoffmann La Roche Ltd.
o Exhibit 150: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 151: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 152: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 153: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 154: F. Hoffmann La Roche Ltd. – Segment focus
o 12.9 Gilead Sciences Inc.
o Exhibit 155: Gilead Sciences Inc. – Overview
o Exhibit 156: Gilead Sciences Inc. – Product / Service
o Exhibit 157: Gilead Sciences Inc. – Key news
o Exhibit 158: Gilead Sciences Inc. – Key offerings
o 12.10 Johnson and Johnson Services Inc.
o Exhibit 159: Johnson and Johnson Services Inc. – Overview
o Exhibit 160: Johnson and Johnson Services Inc. – Business segments
o Exhibit 161: Johnson and Johnson Services Inc. – Key news
o Exhibit 162: Johnson and Johnson Services Inc. – Key offerings
o Exhibit 163: Johnson and Johnson Services Inc. – Segment focus
o 12.11 Lonza Group Ltd.
o Exhibit 164: Lonza Group Ltd. – Overview
o Exhibit 165: Lonza Group Ltd. – Business segments
o Exhibit 166: Lonza Group Ltd. – Key news
o Exhibit 167: Lonza Group Ltd. – Key offerings
o Exhibit 168: Lonza Group Ltd. – Segment focus
o 12.12 Merck and Co. Inc.
o Exhibit 169: Merck and Co. Inc. – Overview
o Exhibit 170: Merck and Co. Inc. – Business segments
o Exhibit 171: Merck and Co. Inc. – Key news
o Exhibit 172: Merck and Co. Inc. – Key offerings
o Exhibit 173: Merck and Co. Inc. – Segment focus
o 12.13 Novartis AG
o Exhibit 174: Novartis AG – Overview
o Exhibit 175: Novartis AG – Business segments
o Exhibit 176: Novartis AG – Key offerings
o Exhibit 177: Novartis AG – Segment focus
o 12.14 Pfizer Inc.
o Exhibit 178: Pfizer Inc. – Overview
o Exhibit 179: Pfizer Inc. – Product / Service
o Exhibit 180: Pfizer Inc. – Key news
o Exhibit 181: Pfizer Inc. – Key offerings
o 12.15 Sanofi SA
o Exhibit 182: Sanofi SA – Overview
o Exhibit 183: Sanofi SA – Business segments
o Exhibit 184: Sanofi SA – Key news
o Exhibit 185: Sanofi SA – Key offerings
o Exhibit 186: Sanofi SA – Segment focus
o 12.16 Takeda Pharmaceutical Co. Ltd.
o Exhibit 187: Takeda Pharmaceutical Co. Ltd. – Overview
o Exhibit 188: Takeda Pharmaceutical Co. Ltd. – Product / Service
o Exhibit 189: Takeda Pharmaceutical Co. Ltd. – Key news
o Exhibit 190: Takeda Pharmaceutical Co. Ltd. – Key offerings
o 12.17 Thermo Fisher Scientific Inc.
o Exhibit 191: Thermo Fisher Scientific Inc. – Overview
o Exhibit 192: Thermo Fisher Scientific Inc. – Business segments
o Exhibit 193: Thermo Fisher Scientific Inc. – Key news
o Exhibit 194: Thermo Fisher Scientific Inc. – Key offerings
o Exhibit 195: Thermo Fisher Scientific Inc. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 196: Inclusions checklist
o Exhibit 197: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 198: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 199: Research methodology
o Exhibit 200: Validation techniques employed for market sizing
o Exhibit 201: Information sources
o 13.5 List of abbreviations
o Exhibit 202: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Application
Exhibits6: Executive Summary – Chart on Market Segmentation by Technology
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on global precision medicine market 2017 – 2021 ($ billion)
Exhibits19: Historic Market Size – Application Segment 2017 – 2021 ($ billion)
Exhibits20: Historic Market Size – Technology Segment 2017 – 2021 ($ billion)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ billion)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ billion)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Application – Market share 2022-2027 (%)
Exhibits31: Data Table on Application – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on Oncology – Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on Oncology – Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on Oncology – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Oncology – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on CNS – Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on CNS – Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on CNS – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on CNS – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Respiratory – Market size and forecast 2022-2027 ($ billion)
Exhibits43: Data Table on Respiratory – Market size and forecast 2022-2027 ($ billion)
Exhibits44: Chart on Respiratory – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Respiratory – Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Immunology – Market size and forecast 2022-2027 ($ billion)
Exhibits47: Data Table on Immunology – Market size and forecast 2022-2027 ($ billion)
Exhibits48: Chart on Immunology – Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Immunology – Year-over-year growth 2022-2027 (%)
Exhibits50: Chart on Others – Market size and forecast 2022-2027 ($ billion)
Exhibits51: Data Table on Others – Market size and forecast 2022-2027 ($ billion)
Exhibits52: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits53: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits54: Market opportunity by Application ($ billion)
Exhibits55: Data Table on Market opportunity by Application ($ billion)
Exhibits56: Chart on Technology – Market share 2022-2027 (%)
Exhibits57: Data Table on Technology – Market share 2022-2027 (%)
Exhibits58: Chart on Comparison by Technology
Exhibits59: Data Table on Comparison by Technology
Exhibits60: Chart on Bioinformatics – Market size and forecast 2022-2027 ($ billion)
Exhibits61: Data Table on Bioinformatics – Market size and forecast 2022-2027 ($ billion)
Exhibits62: Chart on Bioinformatics – Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Bioinformatics – Year-over-year growth 2022-2027 (%)
Exhibits64: Chart on Gene sequencing – Market size and forecast 2022-2027 ($ billion)
Exhibits65: Data Table on Gene sequencing – Market size and forecast 2022-2027 ($ billion)
Exhibits66: Chart on Gene sequencing – Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on Gene sequencing – Year-over-year growth 2022-2027 (%)
Exhibits68: Chart on Drug discovery – Market size and forecast 2022-2027 ($ billion)
Exhibits69: Data Table on Drug discovery – Market size and forecast 2022-2027 ($ billion)
Exhibits70: Chart on Drug discovery – Year-over-year growth 2022-2027 (%)
Exhibits71: Data Table on Drug discovery – Year-over-year growth 2022-2027 (%)
Exhibits72: Chart on Precision molecular diagnostic – Market size and forecast 2022-2027 ($ billion)
Exhibits73: Data Table on Precision molecular diagnostic – Market size and forecast 2022-2027 ($ billion)
Exhibits74: Chart on Precision molecular diagnostic – Year-over-year growth 2022-2027 (%)
Exhibits75: Data Table on Precision molecular diagnostic – Year-over-year growth 2022-2027 (%)
Exhibits76: Chart on Big data analytics – Market size and forecast 2022-2027 ($ billion)
Exhibits77: Data Table on Big data analytics – Market size and forecast 2022-2027 ($ billion)
Exhibits78: Chart on Big data analytics – Year-over-year growth 2022-2027 (%)
Exhibits79: Data Table on Big data analytics – Year-over-year growth 2022-2027 (%)
Exhibits80: Market opportunity by Technology ($ billion)
Exhibits81: Data Table on Market opportunity by Technology ($ billion)
Exhibits82: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits83: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits84: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits85: Chart on Geographic comparison
Exhibits86: Data Table on Geographic comparison
Exhibits87: Chart on North America – Market size and forecast 2022-2027 ($ billion)
Exhibits88: Data Table on North America – Market size and forecast 2022-2027 ($ billion)
Exhibits89: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Europe – Market size and forecast 2022-2027 ($ billion)
Exhibits92: Data Table on Europe – Market size and forecast 2022-2027 ($ billion)
Exhibits93: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Asia – Market size and forecast 2022-2027 ($ billion)
Exhibits96: Data Table on Asia – Market size and forecast 2022-2027 ($ billion)
Exhibits97: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
Exhibits100: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
Exhibits101: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on US – Market size and forecast 2022-2027 ($ billion)
Exhibits104: Data Table on US – Market size and forecast 2022-2027 ($ billion)
Exhibits105: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on Germany – Market size and forecast 2022-2027 ($ billion)
Exhibits108: Data Table on Germany – Market size and forecast 2022-2027 ($ billion)
Exhibits109: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits111: Chart on China – Market size and forecast 2022-2027 ($ billion)
Exhibits112: Data Table on China – Market size and forecast 2022-2027 ($ billion)
Exhibits113: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits114: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits115: Chart on UK – Market size and forecast 2022-2027 ($ billion)
Exhibits116: Data Table on UK – Market size and forecast 2022-2027 ($ billion)
Exhibits117: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits118: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits119: Chart on Japan – Market size and forecast 2022-2027 ($ billion)
Exhibits120: Data Table on Japan – Market size and forecast 2022-2027 ($ billion)
Exhibits121: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits122: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits123: Market opportunity By Geographical Landscape ($ billion)
Exhibits124: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits125: Impact of drivers and challenges in 2022 and 2027
Exhibits126: Overview on Criticality of inputs and Factors of differentiation
Exhibits127: Overview on factors of disruption
Exhibits128: Impact of key risks on business
Exhibits129: Vendors covered
Exhibits130: Matrix on vendor position and classification
Exhibits131: Amgen Inc. – Overview
Exhibits132: Amgen Inc. – Product / Service
Exhibits133: Amgen Inc. – Key offerings
Exhibits134: AstraZeneca Plc – Overview
Exhibits135: AstraZeneca Plc – Product / Service
Exhibits136: AstraZeneca Plc – Key news
Exhibits137: AstraZeneca Plc – Key offerings
Exhibits138: Bristol Myers Squibb Co. – Overview
Exhibits139: Bristol Myers Squibb Co. – Product / Service
Exhibits140: Bristol Myers Squibb Co. – Key news
Exhibits141: Bristol Myers Squibb Co. – Key offerings
Exhibits142: Catalent Inc. – Overview
Exhibits143: Catalent Inc. – Business segments
Exhibits144: Catalent Inc. – Key news
Exhibits145: Catalent Inc. – Key offerings
Exhibits146: Catalent Inc. – Segment focus
Exhibits147: Eli Lilly and Co. – Overview
Exhibits148: Eli Lilly and Co. – Product / Service
Exhibits149: Eli Lilly and Co. – Key offerings
Exhibits150: F. Hoffmann La Roche Ltd. – Overview
Exhibits151: F. Hoffmann La Roche Ltd. – Business segments
Exhibits152: F. Hoffmann La Roche Ltd. – Key news
Exhibits153: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits154: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits155: Gilead Sciences Inc. – Overview
Exhibits156: Gilead Sciences Inc. – Product / Service
Exhibits157: Gilead Sciences Inc. – Key news
Exhibits158: Gilead Sciences Inc. – Key offerings
Exhibits159: Johnson and Johnson Services Inc. – Overview
Exhibits160: Johnson and Johnson Services Inc. – Business segments
Exhibits161: Johnson and Johnson Services Inc. – Key news
Exhibits162: Johnson and Johnson Services Inc. – Key offerings
Exhibits163: Johnson and Johnson Services Inc. – Segment focus
Exhibits164: Lonza Group Ltd. – Overview
Exhibits165: Lonza Group Ltd. – Business segments
Exhibits166: Lonza Group Ltd. – Key news
Exhibits167: Lonza Group Ltd. – Key offerings
Exhibits168: Lonza Group Ltd. – Segment focus
Exhibits169: Merck and Co. Inc. – Overview
Exhibits170: Merck and Co. Inc. – Business segments
Exhibits171: Merck and Co. Inc. – Key news
Exhibits172: Merck and Co. Inc. – Key offerings
Exhibits173: Merck and Co. Inc. – Segment focus
Exhibits174: Novartis AG – Overview
Exhibits175: Novartis AG – Business segments
Exhibits176: Novartis AG – Key offerings
Exhibits177: Novartis AG – Segment focus
Exhibits178: Pfizer Inc. – Overview
Exhibits179: Pfizer Inc. – Product / Service
Exhibits180: Pfizer Inc. – Key news
Exhibits181: Pfizer Inc. – Key offerings
Exhibits182: Sanofi SA – Overview
Exhibits183: Sanofi SA – Business segments
Exhibits184: Sanofi SA – Key news
Exhibits185: Sanofi SA – Key offerings
Exhibits186: Sanofi SA – Segment focus
Exhibits187: Takeda Pharmaceutical Co. Ltd. – Overview
Exhibits188: Takeda Pharmaceutical Co. Ltd. – Product / Service
Exhibits189: Takeda Pharmaceutical Co. Ltd. – Key news
Exhibits190: Takeda Pharmaceutical Co. Ltd. – Key offerings
Exhibits191: Thermo Fisher Scientific Inc. – Overview
Exhibits192: Thermo Fisher Scientific Inc. – Business segments
Exhibits193: Thermo Fisher Scientific Inc. – Key news
Exhibits194: Thermo Fisher Scientific Inc. – Key offerings
Exhibits195: Thermo Fisher Scientific Inc. – Segment focus
Exhibits196: Inclusions checklist
Exhibits197: Exclusions checklist
Exhibits198: Currency conversion rates for US$
Exhibits199: Research methodology
Exhibits200: Validation techniques employed for market sizing
Exhibits201: Information sources
Exhibits202: List of abbreviations



★調査レポート[精密医療のグローバル市場2023~2027:腫瘍、中枢神経系疾患、呼吸器疾患、免疫疾患、その他] (コード:IRTNTR75258-23)販売に関する免責事項を必ずご確認ください。
★調査レポート[精密医療のグローバル市場2023~2027:腫瘍、中枢神経系疾患、呼吸器疾患、免疫疾患、その他]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆